Recent advances in the management of obesity;Actualités thérapeutiques dans le domaine de l'obésité

Revue Medicale de Liege

Volumn 62, Issue 5-6, 2007, Pages 329-334

  Rorive, M ^a,b,c   De Flines, J ^a,b,c   Paquot, N ^a,b,c   De Roover, A ^c   Scheen, A J ^a,b,c  

^a ULg ^*

^b Centre de l'Obésité

^c CHU SART TILMAN   (Belgium)

Author keywords

Bariatric surgery; Diet; Obesity; Orlistat; Rimonabant; Sibutramine

Indexed keywords

PLACEBO; RIMONABANT; SIBUTRAMINE; TETRAHYDROLIPSTATIN;

APPETITE; BARIATRIC SURGERY; BODY WEIGHT; CALORIC DENSITY; CLINICAL TRIAL; COMORBIDITY; DISEASE ASSOCIATION; DISEASE SEVERITY; EXERCISE; GLYCEMIC CONTROL; HUMAN; LIFESTYLE MODIFICATION; LIPID ABSORPTION; OBESITY; REVIEW; RISK FACTOR; STOMACH BYPASS; WEIGHT REDUCTION; DECISION TREE;

DECISION TREES; HUMANS; OBESITY;

EID: 35548941953     PISSN: 00353663     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (36)

1. World Health Organization. - Obesity : preventing and managing the global epidemic. Report of a WHO consultation. WHO Tech Rep Ser, 2000, 894, 1-253.
2. Kopelman PG. - Obesity as a medical problem. Nature, 2000, 404, 635-643.
3. Scheen AJ. - Diabetes, obesity, and metabolic syndrome. In : Nutrient-drug interactions (Ed : Meckling KA), CRC Press Taylor & Francis, Boca Raton, FL, US, 2007, 1-30.
4. Després JP, Lemieux I. - Abdominal obesity and metabolic syndrome. Nature, 2006, 444, 881-887.
5. Van Gaal LF, Mertens IL, De Block CE. - Mechanisms linking obesity with cardiovascular disease. Nature, 2006, 444, 875-880.
6. Paquot N. - Le régime alimentaire chez le patient diabétique de type 2. Rev Med Liège, 2005, 60, 391-394.
7. Rorive M, Letiexhe MR, Scheen AJ, Ziegler O. - Obésité et diabète de type 2. Rev Med Liège, 2005, 60, 374-382.
8. Mobbs CV, Mastaitis J, Yen K, et al. - Low-carbohydrate diets cause obesity, low-carbohydrate diets reverse obesity : a metabolic mechanism resolving the paradox. Appetite, 2007, 48, 135-138.
9. Astrup A, Meinert Larsen T, Harper A. - Atkins and other low-carbohydrate diets : hoax or an effective tool for weight loss ? Lancet, 2004, 364, 897-899.
10. Scheen A, Scheen-Lavigne M, Luyckx A. - La cure de diète protéique dans le traitement de l'obésité. Rev Med Liège, 1980, 35, 477-489.
11. Gilden Tsai A, Wadden TA. - The evolution of very-low-calorie diets : an update and meta-analysis. Obesity, 2006, 14, 1283-1293.
12. Scheen AJ, Rorive M, Letiexhe M. - L'exercice physique pour prévenir l'obésité, favoriser l'amaigrissement et maintenir la perte pondérale. Rev Med Liège, 2001, 56, 244-247.
13. Scheen AJ, Lefèbvre PJ. - Pharmacological treatment of obesity: present status. Int J Obes, 1999, 23, 47-53.
14. Ioannides-Demos LL, Proietto J, McNeil JJ. - Pharmacotherapy for obesity. Drugs. 2005, 65, 1391-1418.
15. Scheen AJ, Paquot N. - Pharmacological treatment of obesity, food intake, and reversal of metabolic disorders. Curr Nutr Food Sci, 2007, 3, 123-133.
16. Padwal R, Li SK, Lau DC. - Long-term pharmacotherapy for obesity and overweight. Cochrane Database Syst Rev, 2004, 3, CD004094.
17. Scheen AJ, Ernest Ph, Letiexhe MR. - Le médicament du mois. L'orlistat (Xenical ®). Rev Med Liège, 1999, 54, 192-196.
18. Curran MP, Scott LJ. - Orlistat : a review of its use in the management of patients with obesity. Drugs, 2004, 64, 2845-2864.
19. Torgerson JS, Hauptman J, Boldrin MN, Sjöström L. - Xenical in the Prevention of Diabetes in Obese Subjects (XENDOS) study. A randomised study of orlistat as an adjunct to lifestyle for the prevention of type 2 diabetes in obese patients. Diabetes Care, 2004, 27, 155-161.
20. Arterburn DE, Crane PK, Veenstra DL. - The efficacy and safety of sibutramine for weight loss : a systematic review. Arch Intern Med, 2004, 164, 994-1003.
21. James WPT, Astrup A, Finer N, et al. for the STORM Study Group. - Effect of sibutramine on weight maintenance after weight loss : A randomised trial. Lancet, 2000, 356, 2119-2125.
22. James WPT. - The SCOUT study : risk-benefit profile of sibutramine in overweight high-risk cardiovascular patients. Eur Heart J, 2005, 7, L44-48.
23. Pagotto U, Marsicano G, Cota D, et al. - The emerging role of the endocannabinoid system in endocrine regulation and energy balance. Endocr Rev, 2006, 27, 73-100.
24. Scheen AJ, Van Gaal LF. - Effets cardio-métaboliques du rimonabant chez le sujet obèse ou en surpoids avec dyslipidémie ou diabète de type 2. Rev Med Liège, 2007, 62, 81-85.
25. Foster-Chubert KE, Cummings DE. - Emerging therapeutic strategies for obesity. Endocr Rev, 2006, 27, 779-793.
26. Scheen AJ, Luyckx FH, Desaive C, Lefèbvre PJ. - Severe/extreme obesity : a surgical treatment for a medical disease ? Acta Clin Belg, 1999, 54, 154-161.
27. Scheen AJ. - Place de la chirurgie bariatrique dans le traitement de l'obésité. In : Traité de Diabetologie (Ed: Grimaldi A.), Flammarion, Paris, France, 2005, 368-375.
28. Buchwald H, Avidor Y, Braunwald E, et al. - Bariatric surgery : a systematic review and meta-analysis. JAMA, 2004, 292, 1724-1737.
29. Scheen AJ, Letiexhe M, Rorive M, et al. - Chirurgie bariatrique : les résultats à 10 ans de la «Swedish Obese Subjects Study». Rev Med Liège, 2005, 60, 121-125.
30. Fried M, Hainer V, Basdevant A, et al. - lnter-disciplinary European guidelines on surgery of severe obesity. Int J Obesity, 2007, 4, 569-577
31. le Roux CW, Aylwin SJ, Batterham RL, et al. - Gut hormone profiles following bariatric surgery favor an anorectic state, facilitate weight loss, and improve metabolic parameters. Ann Surg, 2006, 243, 108-114.
32. McTigue KM, Harris R, Hemphill B, et al. - Screening and interventions for obesity in adults: summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med, 2003, 139, 933-949.
33. Scheen AJ. - Integrated approach to treatment and prevention. In : Pharmacotherapy of obesity. Options and alternatives (Eds : Hofbauer K.G., Keller U., Boss O.), CRC Press, Boca Raton, Florida, USA, 2004, 449-463.
34. Scheen AJ, Rorive M, Letiexhe M, et al. - Comment je traite... Un sujet obèse par une approche multidisciplinaire : l'exemple du Centre de l'Obésité du CHU Ourthe-Amblève. Rev Med Liège, 2001, 56, 474-479.
35. Scheen AJ, Luyckx FH. - Comment j'explore ... un sujet avec un excès pondéral ou une obésité. Rev Med Liège, 1999, 54, 553-556.
36. Belgian association for the stuy of obesity. - Le consensus du BASO. Un guide pratique pour l'évaluation et le traitement de l'excès de poids. Ed. 2002, pp.57.